159 related articles for article (PubMed ID: 37505211)
1. Evidence-based consensus guidelines for the diagnosis and management of protoporphyria-related liver dysfunction in erythropoietic protoporphyria and X-linked protoporphyria.
Levy C; Dickey AK; Wang B; Thapar M; Naik H; Keel SB; Saberi B; Beaven SW; Rudnick SR; Elmariah SB; Erwin AL; Goddu RJ; Hedstrom K; Leaf RK; Kazamel M; Mazepa M; Philpotts LL; Quigley J; Raef H; Ungar J; Anderson KE; Balwani M;
Hepatology; 2024 Mar; 79(3):731-743. PubMed ID: 37505211
[No Abstract] [Full Text] [Related]
2. Hepatobiliary and Pancreatic: A rare cause of decompensated liver cirrhosis.
Dong XQ; Li J; Liu H; Wang YW; Wang H; Huo N; Wang Y; Zhao H
J Gastroenterol Hepatol; 2018 Nov; 33(11):1820. PubMed ID: 29862561
[No Abstract] [Full Text] [Related]
3. X-linked dominant protoporphyria: The first reported Japanese case.
Ninomiya Y; Kokunai Y; Tanizaki H; Akasaka E; Nakano H; Moriwaki S
J Dermatol; 2016 Apr; 43(4):414-8. PubMed ID: 26387792
[TBL] [Abstract][Full Text] [Related]
4. Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria.
Balwani M; Naik H; Anderson KE; Bissell DM; Bloomer J; Bonkovsky HL; Phillips JD; Overbey JR; Wang B; Singal AK; Liu LU; Desnick RJ
JAMA Dermatol; 2017 Aug; 153(8):789-796. PubMed ID: 28614581
[TBL] [Abstract][Full Text] [Related]
5. X-linked dominant protoporphyria: a new porphyria.
Seager MJ; Whatley SD; Anstey AV; Millard TP
Clin Exp Dermatol; 2014 Jan; 39(1):35-7. PubMed ID: 24131146
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based consensus guidelines for the diagnosis and management of erythropoietic protoporphyria and X-linked protoporphyria.
Dickey AK; Naik H; Keel SB; Levy C; Beaven SW; Elmariah SB; Erwin AL; Goddu RJ; Hedstrom K; Leaf RK; Kazamel M; Mazepa M; Philpotts LL; Quigley J; Raef H; Rudnick SR; Saberi B; Thapar M; Ungar J; Wang B; Balwani M;
J Am Acad Dermatol; 2023 Dec; 89(6):1227-1237. PubMed ID: 36041558
[TBL] [Abstract][Full Text] [Related]
7. X-linked protoporphyria: Iron supplementation improves protoporphyrin overload, liver damage and anaemia.
Landefeld C; Kentouche K; Gruhn B; Stauch T; Rößler S; Schuppan D; Whatley SD; Beck JF; Stölzel U
Br J Haematol; 2016 May; 173(3):482-4. PubMed ID: 26193873
[No Abstract] [Full Text] [Related]
8. Erythropoietic Protoporphyria and X-Linked Protoporphyria: pathophysiology, genetics, clinical manifestations, and management.
Balwani M
Mol Genet Metab; 2019 Nov; 128(3):298-303. PubMed ID: 30704898
[TBL] [Abstract][Full Text] [Related]
9. Photosensitivity in the elderly-think of late-onset protoporphyria.
Frank J; Poblete-Gutiérrez P; Neumann NJ
J Invest Dermatol; 2013 Jun; 133(6):1467-71. PubMed ID: 23673504
[TBL] [Abstract][Full Text] [Related]
10. How I treat erythropoietic protoporphyria and X-linked protoporphyria.
Leaf RK; Dickey AK
Blood; 2023 Jun; 141(24):2921-2931. PubMed ID: 36898083
[TBL] [Abstract][Full Text] [Related]
11. Loss-of-function ferrochelatase and gain-of-function erythroid-specific 5-aminolevulinate synthase mutations causing erythropoietic protoporphyria and x-linked protoporphyria in North American patients reveal novel mutations and a high prevalence of X-linked protoporphyria.
Balwani M; Doheny D; Bishop DF; Nazarenko I; Yasuda M; Dailey HA; Anderson KE; Bissell DM; Bloomer J; Bonkovsky HL; Phillips JD; Liu L; Desnick RJ;
Mol Med; 2013 Apr; 19(1):26-35. PubMed ID: 23364466
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietic protoporphyria: case reports for clinical and therapeutic hints.
Tumminelli C; Burlo F; Pastore S; Severini GM; Berti I; Marchini S; Zanon D; De Martino E; Tommasini A
Ital J Pediatr; 2023 Nov; 49(1):156. PubMed ID: 37996925
[TBL] [Abstract][Full Text] [Related]
13. Late-onset X-linked dominant protoporphyria: an etiology of photosensitivity in the elderly.
Livideanu CB; Ducamp S; Lamant L; Gouya L; Rauzy OB; Deybach JC; Paul C; Puy H; Marguery MC
J Invest Dermatol; 2013 Jun; 133(6):1688-90. PubMed ID: 23223129
[No Abstract] [Full Text] [Related]
14. Erythropoietic Protoporphyria in a Japanese Population.
Mizawa M; Makino T; Nakano H; Sawamura D; Shimizu T
Acta Derm Venereol; 2019 Jun; 99(7):634-639. PubMed ID: 30938825
[TBL] [Abstract][Full Text] [Related]
15. Cholestyramine resin for erythropoietic protoporphyria with severe hepatic disease: a case report.
Yoo DJ; Lee HC; Yu E; Jin YJ; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS; Suh DJ
Korean J Hepatol; 2010 Mar; 16(1):83-8. PubMed ID: 20375647
[TBL] [Abstract][Full Text] [Related]
16. Annular elastolytic giant cell granuloma associated to late-onset X-linked dominant protoporphyria.
García-Martínez FJ; Gutiérrez-González E; Alonso-González J; Vega A; Santamariña M; Rodríguez-Granados MT; Toribio J
Dermatology; 2013; 227(3):238-42. PubMed ID: 24135682
[TBL] [Abstract][Full Text] [Related]
17. Algorithm-based readability assessment of online patient educational material for erythropoietic protoporphyria.
Kulkarni V; Varghese J; Gamsarian V; Lio PA
Int J Dermatol; 2022 Aug; 61(8):e317-e319. PubMed ID: 34346061
[No Abstract] [Full Text] [Related]
18. Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.
Weiss Y; Balwani M; Chen B; Yasuda M; Nazarenko I; Desnick RJ
Mol Genet Metab; 2019 Nov; 128(3):358-362. PubMed ID: 30454868
[TBL] [Abstract][Full Text] [Related]
19. Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury.
Fujimori N; Komatsu M; Tanaka N; Iwaya M; Nakano H; Sugiura A; Yamazaki T; Shibata S; Iwaya Y; Muraki T; Ichikawa Y; Kimura T; Joshita S; Umemura T; Matsumoto A; Tanaka E
Clin J Gastroenterol; 2017 Oct; 10(5):452-458. PubMed ID: 28676994
[TBL] [Abstract][Full Text] [Related]
20. [Inheritance in erythropoietic protoporphyria].
Schmitt C; Ducamp S; Gouya L; Deybach JC; Puy H
Pathol Biol (Paris); 2010 Oct; 58(5):372-80. PubMed ID: 20850938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
